EndoStim receives CE Mark for full body MRI use with EndoStim II LES Stimulation System

NIJMEGEN, Netherlands, Oct. 20, 2015 -- (Healthcare Sales & Marketing Network) -- EndoStim, a medical device company that has developed neurostimulation therapy for gastroesophageal reflux disease (GERD), announced CE Mark approval for a significant expan... Devices, Gastroenterology, RegulatoryEndoStim, gastroesophageal reflux disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news